Long-term prognosis of subclinical sensitization with diphenylcyclopropenone in patients with alopecia areata

J Am Acad Dermatol. 2023 Apr;88(4):912-914. doi: 10.1016/j.jaad.2022.10.044. Epub 2022 Oct 28.

Authors

Sang-Hoon Lee¹, Yeon Woo Heo¹, Won-Soo Lee²

Affiliations

¹ Department of Dermatology and Institute of Hair and Cosmetic Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.
² Department of Dermatology and Institute of Hair and Cosmetic Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea. Electronic address: [email protected].

PMID: 37650451
DOI: 10.1016/j.jaad.2022.10.044

No abstract available

MeSH terms

Alopecia Areata* / drug therapy
Cyclopropanes / adverse effects
Humans
Prognosis

Substances

diphenylcyclopropenone
Cyclopropanes

Supplementary concepts

Diffuse alopecia